Huons Meditech Discusses Local Assembly Production Collaboration with India’s Vasu Group 

- Strengthening global cooperation through partner invitation meeting-

Huons Meditech CEO Changwoo Ha (left) shakes hands with Vasu Group CEO Abhinay Bejgam (right).

Huons Meditech, a medical device subsidiary of Huons Group, announced on the 19th that it held strategic discussions with its Indian partner regarding local assembly production and global business expansion.

Huons Meditech (CEO Changwoo Ha) recently invited core executives of Vasu Group to Korea to discuss detailed strategies for entering the Indian market.

Vasu Group, founded in 1985, is a pharmaceutical and medical device distribution company based in Telangana and Andhra Pradesh, operating a nationwide distribution network across India. Huons Meditech signed an agreement with Vasu Group in March to advance into the Indian market, and this meeting served as an opportunity to further refine concrete plans.

During the meeting, the two companies discussed medical device business strategies with a focus on local assembly production (as known as Complete Knock Down, CKD). Huons Meditech shared updates on the global supply status and technological advancement roadmap of its extracorporeal shockwave lithotriptors, as well as the 2025 production plan and overseas rollout schedule for its endoscope reprocessors.

Vasu Group emphasized the strategic importance of local assembly and phased localization for the endoscope reprocessor line, which prioritizes domestically produced products, and the complexities associated with local medical device registration.

Both companies agreed that introducing the CKD model in India could deliver significant benefits, including enhanced price competitiveness, improved logistics efficiency, reduced regulatory risks, and accelerated market expansion.

Huons Meditech CEO Changwoo Ha stated, “The CKD model in India will play a key role in Huons Meditech’s global expansion strategy for 2026. We will continue to strengthen our collaboration with Vasu Group, especially in extracorporeal shockwave lithotriptors, endoscope reprocessors, and disinfectant products, to further penetrate global markets.”

Huons Meditech plans to further detail the CKD collaboration model for the Indian market and accelerate its overseas expansion based on this strategic partnership.